LabCorp Sets Dedicated Hours to Serve the Non-COVID-19 Testing Needs for Elderly and Most Vulnerable People
March 19 2020 - 3:01PM
Business Wire
LabCorp ‘Wait Where You’re Comfortable’ and
Mobile Check-In Options Reinforce Social Distancing Protocols
LabCorp (NYSE: LH), a leading global life sciences company that
is deeply integrated in guiding patient care, today announced that
it is dedicating the first hour of service each day at its nearly
2,000 patient service centers (PSCs) across the U.S. for the
non-COVID-19 testing needs of its most vulnerable patients. The
option is aimed at making it easier for patients who are at higher
risk to practice social distancing and get their critical lab
testing services.
LabCorp’s first business hour of each day at PSCs will be
focused on serving people who are 65 or older or who have serious
underlying health conditions. LabCorp will not turn away any
patient during the first business hour but encourages other
patients to plan around this hour to protect vulnerable patients.
Patients who believe they have been exposed to COVID-19 should not
enter the patient service center. They should contact their
physician or healthcare provider.
“Providing this dedicated hour each day for our most vulnerable
patients can help protect those patients and help flatten the
coronavirus curve,” said Adam H. Schechter, president and CEO of
LabCorp. “Enhanced social distancing can limit the potential spread
of the virus and offer greater peace of mind for people who have
important and ongoing health and testing needs. We all have a role
to play in protecting our communities, and we are committed to
doing all we can to ensure the safety and health of those we
serve.”
In addition to the dedicated hour for vulnerable patients, to
further help reduce the risk of transmission of COVID-19 for
patients visiting its PSCs, LabCorp recently launched the “Wait
Where You’re Comfortable” program. Patients can check in from their
mobile device or using the LabCorp Express tablet and then wait in
their car or anywhere else they are comfortable. Patients receive a
text message when it’s their turn to be served. To learn more about
these options, visit:
https://www.LabCorp.com/labs-and-appointments.
About COVID-19 Testing LabCorp does not collect specimens
for the COVID-19 test. LabCorp is playing a vital role in ramping
up testing capacity for COVID-19. LabCorp made testing for COVID-19
available on Thursday, March 5, for ordering by physicians or other
authorized healthcare providers anywhere in the U.S. The test
detects the presence of the underlying virus that causes COVID-19
and is for use with patients who meet current guidance for
evaluation of infection with COVID-19. Patients for whom testing
has been ordered should not be sent to a LabCorp location to have a
specimen collected. Instead, an appropriate specimen must be
collected at the healthcare facility where the patient was seen and
the test was ordered. The specimen should be sent to LabCorp using
standard procedures. For more information on COVID-19 testing,
including specific guidance on specimen collection and handling,
visit: https://www.LabCorp.com/COVID-19.
About LabCorp LabCorp (NYSE: LH), an S&P 500 company,
is a leading global life sciences company that is deeply integrated
in guiding patient care, providing comprehensive clinical
laboratory and end-to-end drug development services. With a mission
to improve health and improve lives, LabCorp delivers world-class
diagnostics solutions, brings innovative medicines to patients
faster, and uses technology to improve the delivery of care.
LabCorp reported revenue of more than $11.5 billion in 2019. To
learn more about LabCorp, visit www.LabCorp.com, and to learn more
about Covance Drug Development, visit www.Covance.com.
Cautionary Statement Regarding Forward-Looking Statements
This press release contains forward-looking statements, including
but not limited to statements with respect to clinical laboratory
testing. Each of the forward-looking statements is subject to
change based on various important factors, many of which are beyond
the Company’s control, including without limitation, competitive
actions and other unforeseen changes and general uncertainties in
the marketplace, changes in government regulations, including
healthcare reform, customer purchasing decisions, including changes
in payer regulations or policies, other adverse actions of
governmental and third-party payers, the Company’s satisfaction of
regulatory and other requirements, patient safety issues, changes
in testing guidelines or recommendations, adverse results in
material litigation matters, failure to maintain or develop
customer relationships, our ability to develop or acquire new
products and adapt to technological changes, failure in information
technology, systems or data security, and employee relations. These
factors, in some cases, have affected and in the future (together
with other factors) could affect the Company’s ability to implement
the Company’s business strategy and actual results could differ
materially from those suggested by these forward-looking
statements. As a result, readers are cautioned not to place undue
reliance on any of our forward-looking statements. The Company has
no obligation to provide any updates to these forward-looking
statements even if its expectations change. All forward-looking
statements are expressly qualified in their entirety by this
cautionary statement. Further information on potential factors,
risks and uncertainties that could affect operating and financial
results is included in the Company’s most recent Annual Report on
Form 10-K and subsequent Forms 10-Q, including in each case under
the heading RISK FACTORS, and in the Company’s other filings with
the SEC.
###
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200319005718/en/
Media: Pattie Kushner — 336-436-8263 Media@LabCorp.com
Investors: Clarissa Willett —
336-436-5076 Investor@LabCorp.com
Laboratory Corporation o... (NYSE:LH)
Historical Stock Chart
From Mar 2024 to Apr 2024
Laboratory Corporation o... (NYSE:LH)
Historical Stock Chart
From Apr 2023 to Apr 2024